Fortis Healthcare (FORTIS) Fundamentals 2026 — P/E 68.8x, Revenue Analysis | SniperIQ
Fortis Healthcare (FORTIS) is a India-listed Healthcare company in Medical - Care Facilities with a market capitalization of ₹71,669 Crore, trading at ₹949.55 on the BSE. This SniperIQ fundamentals page covers Fortis Healthcare's valuation (P/E 68.8x, P/B 7.2x), profitability (net margin 11.4%), revenue (₹9,128 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Fortis Healthcare's market cap?
Fortis Healthcare (FORTIS) has a market capitalization of approximately ₹71,669 Crore, trading at ₹949.55 on the BSE. Market cap moves with the live share price.
What is Fortis Healthcare's P/E ratio?
Fortis Healthcare's trailing twelve-month P/E ratio is 68.8x, with a price-to-book (P/B) of 7.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Fortis Healthcare?
Fortis Healthcare runs a net profit margin of 11.4%, a gross margin of 42.4%, and an operating margin of 23.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Fortis Healthcare generate?
Fortis Healthcare reported revenue of ₹9,128 Crore for fiscal year 2026, with net income of ₹1,042 Crore and earnings per share (EPS) of 13.8. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Fortis Healthcare pay a dividend?
Fortis Healthcare offers a trailing dividend yield of about 0.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Fortis Healthcare financially healthy?
Fortis Healthcare carries a debt-to-equity ratio of 0.35x and a current ratio of 0.86x, with a market beta of 0.65. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Fortis Healthcare a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Fortis Healthcare (FORTIS) the key facts are: market cap ₹71,669 Crore, P/E 68.8x, revenue ₹9,128 Crore, 52-week range 767.3-1105. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Fortis Healthcare's full fundamentals live
Get Fortis Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.